Use of Guidelines and Risk Stratification in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Grossman, Ronald F.

doi:10.1055/s-2000-9932

Cited by 8 publications

(1 citation statement)

References 43 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A number of national and international guidelines have recommended the ideal management of COPD subjects [17]. Recent papers, however, have highlighted disparities among these COPD guidelines [18,19]. The recently released Global Obstructive Lung Disease guidelines [20], jointly sponsored by the US National Heart, Lung and Blood Institute and the WHO, were developed to provide a more uniform set of recommendations for the diagnosis and management of COPD and to increase subject and public awareness and understanding of this condition [21,22].…”

mentioning

confidence: 99%

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

Rennard¹,

Decramer²,

Calverley³

et al. 2002

European Respiratory Journal

496

331

View full text Add to dashboard Cite

To date, no international surveys estimating the burden of chronic obstructive pulmonary disease (COPD) in the general population have been published. The Confronting COPD International Survey aimed to quantify morbidity and burden in COPD subjects in 2000.From a total of 201,921 households screened by random-digit dialling in the USA, Canada, France, Italy, Germany, the Netherlands, Spain and the UK, 3,265 subjects with a diagnosis of COPD, chronic bronchitis or emphysema, or with symptoms of chronic bronchitis, were identified.The mean age of the subjects was 63.3 yrs and 44.2% were female. Subjects with COPD in North America and Europe appear to underestimate their morbidity, as shown by the high proportion of subjects with limitations to their basic daily life activities, frequent work loss (45.3% of COPD subjects of v65 yrs reported work loss in the past year) and frequent use of health services (13.8% of subjects required emergency care in the last year), and may be undertreated. There was a significant disparity between subjects9 perception of disease severity and the degree of severity indicated by an objective breathlessness scale. Of those with the most severe breathlessness (too breathless to leave the house), 35.8% described their condition as mild or moderate, as did 60.3% of those with the next most severe degree of breathlessness (breathless after walking a few minutes on level ground).This international survey confirmed the great burden to society and high individual morbidity associated with chronic obstructive pulmonary disease in subjects in North America and Europe. Eur Respir J 2002; 20: 799-805.

show abstract

mentioning

confidence: 99%

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

Rennard¹,

Decramer²,

Calverley³

et al. 2002

European Respiratory Journal

496

331

View full text Add to dashboard Cite

show abstract

Chronic Obstructive Pulmonary Disease Exacerbation

Domínguez-Cherit¹,

Nava²

2004

Sepsis

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPO) is the only leading cause of death with a rising prevalence It is the fourth leading cause of death in the United States and accounts for approximately 500,000 hospitalizations and 110,000 deaths for exacerbations each year. Patients who are admitted to the intensive care unite (ICU) for COPO exacerbations have an in-hospital mortality of 24%.1-4 It has been estimated that by the year 2020, COPO will be fifth among the conditions that will be the most burden to society.5Morbidity and mortality due to COPO vary dramatically between industrialized countries. These variations have been attributed to different exposures to risk factors such as tobacco, atopy, occupational hazards, genetic factors, and air pollution. Outside the United States, COPO has had a similar impact on health and mortality throughout the developed and underdeveloped world, and many of the important issues surrounding COPO in the United States applyelsewhere. 6 DefinitionsThe term COPD, as recommended by the American Thoracic Society, must be applied to patients who have chronic bronchitis and/or emphysema with significant airflow limitation that does not change significantly over a period of several months of observation, thus distinguishing these patients from those with asthma. 5New definitions of acute COPO exacerbation (AECOPO) have been suggested, but the one widely accepted is generally considered as the presence of one or more of the following findings: increase in sputum purulence, increase in sputum volume, and worsening of dyspnea. Patients with COPO present acute decompensation one to three times a year, and 3% to 10% require hospitalization.1.2 Assessment of the magnitude of these three symptoms can determine the severity of an exacerbation. When all three symptoms are present, it is a type I exacerbation. If any two of the three symptoms are present, it is 101 G. Ortiz-Ruiz et al. (eds.), Sepsis

show abstract

Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians

Luo,

Tang,

et al. 2024

Respiratory Medicine

View full text Add to dashboard Cite

Use of Guidelines and Risk Stratification in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Cited by 8 publications

References 43 publications

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey

Chronic Obstructive Pulmonary Disease Exacerbation

Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians

Contact Info

Product

Resources

About